The BioCentury Show
The BioCentury Show
BioCentury
Ep. 94 - Frazier's James Li on China’s Rapidly Evolving Biotech Deal Landscape
29 minutes Posted Oct 3, 2025 at 11:00 pm.
Introduction
Evolution of an Ecosystem
NewCo Deals
Japan, Korea
Dealmaking
0:00
29:45
Download MP3
Show notes
The frenzy among Western companies to access China’s biotechnology innovation is remaking the landscape for cross-border dealmaking, with assets becoming more expensive and partnerships earlier and broader than ever before. That’s being driven by exceptional capital efficiency, access to patients and speed of development, said Frazier Life Sciences’ James Li on The BioCentury Show podcast. Among multinational companies, “every company has an army on the ground hunting for assets,” said Li, wh...